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Very Late Antigen-4 (CD49d/CD29, alpha4 beta1) and Lymphocyte Function-associated
Antigen-1 (CD11a/CD18, alphaL beta2) integrins are representatives of a large family of
adhesion receptors widely expressed on immune cells. They participate in cell recruitment
to sites of inflammation, as well as multiple immune cell interactions. A unique feature of
integrins is that integrin-dependent cell adhesion can be rapidly and reversibly modulated
in response to cell signaling, because of a series of conformational changes within the
molecule, which include changes in the affinity of the ligand binding pocket, molecular
extension (unbending) and others. Here, we provide a concise comparative analysis of the
conformational regulation of the two integrins with specific attention to the physiological
differences between these molecules. We focus on recent data obtained using a novel
technology, based on small fluorescent ligand-mimicking probes for the detection of
integrin conformation in real-time on live cells at natural receptor abundance.
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INTRODUCTION
Integrins are a large family of adhesion receptors widely expressed
on different cell types that participate in cell-matrix, or cell-cell
interactions. These receptors can transmit signals in two direc-
tions. From the outside of a cell, ligation of the integrins results
in the activation of a number of signaling pathways. Integrins
can also serve as mechanosensors probing mechanical proper-
ties of the extracellular environment (Hogg et al., 2011). Ligation
of other receptors, including different G-protein coupled recep-
tors, cytokine, and chemokine receptors, Fc-receptors and others,
can lead to the propagation of an inside-out signal toward the
integrin (Hogg et al., 2011). This can result in a series of con-
formational changes within integrin molecules leading to a rapid
increase or decrease of the integrin ligand binding affinity, molec-
ular extension (unbending), movement of integrin domains (such
as hybrid domain swing-out), and changes in integrin lateral
mobility. These events directly modulate cell adhesion behavior
(Askari et al., 2009).
In the peripheral blood, the majority of leukocytes exhibit a
non-adhesive phenotype in which cells move freely with flow-
ing blood. On these cells, integrins usually exist in a resting
(inactive) non-adhesive state. On encountering soluble or immo-
bilized ligands cellular behavior can be rapidly altered. Cells may
roll on endothelial cells, arrest and firmly adhere, and transmi-
grate, leaving the blood vessel and crossing the endothelial barrier.
Surprisingly, a number of steps in the cell adhesion cascade can
be mediated by the same integrin molecule, existing in different
conformational states that can be rapid and reversibly regulated
through cellular signaling. Here we discuss recent insights into
integrin conformational regulation. We will focus on two major
leukocyte integrins (CD49d/CD29, Very Late Antigen-4, alpha4
beta1 integrin), and (CD11a/CD18, Lymphocyte Function-
associated Antigen-1, alphaL beta2 integrin).
STRUCTURAL AND FUNCTIONAL DIFFERENCES
BETWEEN THE TWO INTEGRINS
In the membranes of cells, integrins exist as heterodimers com-
posed of one alpha and one beta subunit. In humans, 18 alpha
and 8 beta subunits have been identified that combine to form at
least 24 different heterodimers (Huhtala et al., 2005). An impor-
tant feature of integrins is the presence of the so-called “inserted
domain, or I-domain,” homologous to the von Willebrand fac-
tor A domain (vWFA). It can be found in every beta- (I-like
domain), but only several alpha-subunits. This domain directly
participates in the binding of the integrin ligands. Because of its
homology to the vWFA alpha I-domains several groups prefer the
term A-domain.
The alpha subunit with an inserted I-domain represents a
late evolutionary acquisition. Even though teleost fish and sev-
eral tunicata genomes contain integrin alpha subunits that have
the inserted alpha I-domain, the leukocyte-specific integrin sub-
unit orthologs, which include alpha D, alpha M, alpha X, and
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alpha L, are absent. Moreover, the beta2 integrin subunit that is
known to form a dimer with each of these alpha subunits was
also not found (Huhtala et al., 2005). Thus, it appears that the
development of leukocytes, bearing diverse immune functions (as
found in vertebrates), requires a set of leukocyte-specific integrin
subunits. What would be the major physiological advantage to
have these integrins? To answer this question we have to compare
what is known about the physiological differences between alpha
I-domain containing integrins (such as LFA-1) and leukocyte
integrins lacking alpha I-domain, such as VLA-4.
According to the UniGene EST profile the overall expres-
sion patterns of integrin alpha 4 subunit (ITGA4) and integrin
alpha L subunit (ITGAL) are very similar. These integrins are
expressed in tissues associated with blood and lymphatic tissues.
Blood, bone marrow, lymph, lymph nodes, spleen, and thymus
are primary sites of expression. However, one major difference
is that while LFA-1 expression is usually attributed to mature
leukocytes, VLA-4 integrin is strongly expressed on CD34+ early
hematopoietic stem progenitor cells (HSPCs). VLA-4 expression
is critical for homing and retention of HSPCs, since blocking
VLA-4-specific interactions using mAbs or small molecule antag-
onists is sufficient to induce cell mobilization into peripheral
blood (Coulombel et al., 1997; Oostendorp and Dormer, 1997;
Gazitt, 2004; Chigaev et al., 2011d). This observation is also
confirmed by the fact that the expression of VLA-4 is more
pronounced in “germ cell tumors.” (Compare the VLA-4 and
LFA-1 UniGene EST profiles at http://www.ncbi.nlm.nih.gov/
unigene/).
Twomajor integrin functions, related to cell adhesion, are usu-
ally assigned to VLA-4 and LFA-1. First, these integrins directly
participate in cell arrest under flow, where firm adhesion is medi-
ated by activated (high-affinity, unbent) integrins. Second, VLA-4
and LFA-1 contribute to cell-cell interactions that are critical for
immune system responses. For example, both integrins play a
part in the formation of immunological synapse, and participate
in cell co-stimulation. There are also a number of differences
between the two integrins related to both of these two func-
tions. We postulate that these differences can be related to distinct
structural and functional characteristics of these molecules, and
thus, can provide a clue to the mystery of leukocyte-specific alpha
I-domain-containing integrins.
Integrins are thought to be firm adhesion receptors.
Historically, LFA-1 was one of the first integrins for which firm
cell adhesion on activated cells was described. LFA-1 was unable
to sustain cell rolling, and therefore, a selectin-mediated rolling
step was envisioned to be necessary. However, under specific
conditions that include LFA-1 mutagenesis, truncation, or treat-
ment with allosteric antagonist rolling on LFA-1 can be observed
(Table 1). This led to a multi-step recruitment paradigm, where
cells will first roll on selectins, and after encountering activating
Table 1 | Examples of different functional roles of LFA-1 and VLA-4-dependent adhesive interaction.
Function LFA-1/ICAM-1 interaction VLA-4/VCAM-1 interaction
Tethering or rolling under shear
flow
No tethering or rolling under shear flow; requires
selectin-mediated rolling (Lawrence and Springer, 1991; von
Andrian et al., 1991). No contribution to lymphocyte rolling on
high endothelial venules (Warnock et al., 1998). Rolling can
be artificially induced when mutated I domains or isolated
wild type I domains are used (Salas et al., 2002). Small
molecule allosteric antagonist XVA143 stimulates rolling on
ICAM-1 (Salas et al., 2004).
Shown to mediate tethering or rolling (Alon et al.,
1995; Berlin et al., 1995). Integrin activation is not
required for tethering or rolling (Alon et al., 1995).
Engraftment of
non-obese/severe combined
immunodeficiency mice by
human stem cells
Treatment with anti-LFA-1 antibodies caused partial inhibition
of engraftment (by ∼20%) (Peled et al., 2000).
Treatment with anti-VLA-4 antibodies prevented
engraftment (Peled et al., 2000).
NK cell and NKT cell recruitment
to bone marrow
LFA-1 does not participate (Franitza et al., 2004). VLA-4 is critical for recruitment (Franitza et al., 2004).
Recruitment of cells to lungs
during Streptococus
pneumoniae infection
No LFA-1 contribution found (Kadioglu et al., 2011). T cell recruitment solely dependent on VLA-4;
neutrophil recruitment depends also on Mac-1
(Kadioglu et al., 2011).
Phagosome maturation in
macrophages
Search for “LFA-1 AND phagosome maturation” in PubMed
database returned no items.
VLA-4 (and VLA-5) are critical for phagosome
maturation. Integrin-deficient macrophages have
impaired bactericidal activity (Wang et al., 2008).
T-B-cell interactions in vivo LFA-1/ICAM-1 interactions are critical for polyclonal B-cell
activation in host-versus-graft model (Lopez-Hoyos et al.,
1999).
Blocking of VLA-4 had no effect (Lopez-Hoyos et al.,
1999).
Immunological synapse LFA-1-dependent interaction represent an important part of
immunological synapse, playing a role in adaptive immune
responses (Dustin, 2008; Springer and Dustin, 2012).
Only a few papers describe involvement of VLA-4 in
immunological synapse formation and signaling
(Burkhardt, 2008; Carrasco and Batista, 2006).
Publications where similar integrin functions were reported are not included as the authors intentionally focused on functional differences between the two integrins.
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stimuli they will arrest, and transmigrate (von Andrian et al.,
1991; Springer, 1994). The discovery that in addition to firm
adhesion VLA-4 can mediate cell tethering and rolling (Alon
et al., 1995) represents the first indication of a functional differ-
ence between VLA-4 and LFA-1. More detailed analysis revealed
that VLA-4 supports a number of adhesive interactions that are
directly related but not limited to the maintenance of immune
cells through hematopoiesis (Imai et al., 2010), as well as intrin-
sic immune responses. Thus, VLA-4 participates in chemokine-
dependent cell arrest on endothelium, NK, and MKT cell recruit-
ment to bone marrow, cell recruitment in response to bacterial
infections, bacterial killing, etc. In contrast, LFA-1-dependent cell
adhesion is critical for modulating adaptive immune responses
that include T-B-cell interaction, Antigen Presenting Cell (APC)-
T-cell interaction, regulation of TCR signaling, host-versus-graft
reaction, binding, etc. (Table 1).
Thus, another functional difference between the two inte-
grins is related to their role in the immune system. It appears
that VLA-4, representing an ancient integrin family expressed on
leukocytes, is predominantly related to certain types of innate
antigen-independent non-specific immune responses, where no
significant role for LFA-1 is shown. LFA-1 is predominantly
related to the signaling pathways, where antigen-dependent adap-
tive immunity plays a critical role (Table 1).
Furthermore, the appearance of leukocyte-specific alpha
I-domain-containing integrins during evolution coincides with
the emergence of the BCR-TCR-MHC-based adaptive immune
system. The whole genome duplication that occurred at the dawn
of jawed vertebrate evolution provides a mechanism for the emer-
gence of novel genes that included a set of leukocyte-specific alpha
and beta subunits. The “big bang” that created vertebrate adaptive
immune system could be responsible for leukocyte integrin evolu-
tion as well (Flajnik andKasahara, 2010). Thus, it is not surprising
that leukocyte-specific alpha I-domain-containing integrins, such
as LFA-1, are functionally linked to the adaptive immune system
and BCR/TCR/MHC-related signaling pathways.
FLUORESCENT PROBES AS TOOLS FOR INTEGRIN STUDIES
We postulated that the physiological difference in the integrin
function could be directly related to a primary integrin function:
binding of the integrin ligand under different signaling condi-
tions. To study the real-time regulation of integrin affinity and
conformation, we developed a set of small fluorescent probes.
[For VLA-4 see (Chigaev et al., 2001, 2003b, 2004) and for LFA-
1 see (Chigaev et al., 2011b)]. These molecules were designed
using small molecule integrin antagonists, developed by pharma-
ceutical companies, and have been shown to bind to the natural
ligand binding sites. Therefore, these molecules mimic the bind-
ing of a natural ligand (Chigaev et al., 2003b; Zwartz et al., 2004),
and because of an intrinsically higher affinity and commercial
availability, these probes can be used in homogeneous assays to
study rapid integrin conformational changes on live cell and in
real-time (Chigaev et al., 2003a,b; Chigaev and Sklar, 2012). For
example, for the detection of a real-time affinity change, the
experimental concentration of the probe is required to be below
the dissociation constant (Kd) for its binding to the resting inte-
grin, and above the Kd for the physiologically activated integrin.
Therefore, the transition from the low affinity to the high affinity
state after “inside-out” activation through a G-protein coupled
receptor, leads to an increase in the binding of the probe that can
be detected using a conventional flow cytometer. Physiological
signaling pathways involving cAMP and cGMP that lead to inte-
grin deactivation result in rapid probe dissociation (Chigaev
et al., 2001, 2008, 2011a,b). Moreover, different integrin affini-
ties can be detected through analysis of ligand dissociation rates.
Slower rates correspond to states of higher affinity (Chigaev et al.,
2003b).
Vertical extension of the VLA-4 integrin molecule can be
detected using a FRET-based approach, where a fluorescent probe
bound to the integrin headgroup serves as the donor, and octade-
cyl rhodamine B incorporated into the cell membrane, serves
as the acceptor (Chigaev et al., 2003a, 2007, 2008). Using these
and other approaches (Chigaev et al., 2009) which depend upon
the ability of the flow cytometer to discriminate fluorescent sig-
nals from a cell and the volume around it, a complex picture of
conformational regulation of integrin has emerged.
INTEGRIN CONFORMATION IN THE REGULATION OF
INTEGRIN DEPENDENT CELL ADHESION
Integrins can exist in multiple conformational states. For LFA-
1, at least three states that differ in ligand binding affinity (low,
intermediate, and high affinity) have been reported. Moreover,
application of an external force can lead to the stabilization of
ligand binding [or “catch bond” (Kong et al., 2009)], while lat-
eral shear force can significantly modify the adhesive properties
of LFA-1 (Hogg et al., 2011). For VLA-4, the discovery of several
distinct signaling mechanisms that can independently regulate
the affinity of the ligand-binding pocket and molecular unbend-
ing (or extension, detected using FRET-based approaches), was
an early indication of the conformational complexity of this
non I-domain-containing integrin (Chigaev et al., 2007). Next,
it was found that after inside-out activation through wild type
Gαi-coupled GPCRs, ligand binding affinity andmolecular exten-
sion exhibited distinctly different time courses (Chigaev et al.,
2007). In contrast, the fact that VLA-4 deactivation through
Gαs-coupled GPCRs only affected the affinity of the integrin lig-
and binding pocket (Chigaev et al., 2008), provided a plausible
explanation for the differences in cell adhesion at rest and after
cAMP-dependent integrin deactivation [see Figure 7A in Chigaev
et al. (2008)]. The use of conformationally sensitive antibodies
in real-time on living cells allowed us to answer several ques-
tions regarding the role of the hybrid domain movement during
inside-out activation and ligand engagement as described below
(Chigaev et al., 2009; Njus et al., 2009). Using this information
we can reconstruct a model of integrin conformational states for
a non I-domain containing integrin (VLA-4).
HYBRID DOMAIN
On resting cells, in the absence of ligand, VLA-4 exhibits a low
affinity, bent conformation with a hidden hybrid domain epi-
tope (based on the lack of HUTS mAb binding). Although,
the approach for assessing VLA-4 extension is based on FRET
between the fluorescent ligand bound to the integrin headgroup
and a membrane bound fluorescent acceptor, the observation
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that inside-out activation rapidly induces FRET signal unquench-
ing suggests that at rest the VLA-4 headgroup is closer to the
membrane. The inside-out activation through a Gαi-coupled
GPCR in the absence of a ligand has only a small effect on hybrid
domain movement. In this case, the short-term exposure of the
HUTS epitope was maximal during the first 30 s after GPCR sig-
nal, and it was undetectable 4min after activation based on the
rate of HUTS Mab binding (Chigaev et al., 2009). Under simi-
lar conditions, the high affinity state of the VLA-4 ligand binding
pocket was sustained for more than 15min, in the presence of a
non-desensitizing mutant of the GPCR (Prossnitz, 1997; Chigaev
et al., 2007, 2011a). Thus, at least for VLA-4, no direct connection
between exposure of the hybrid domain epitope [and an outward
swing of a beta-1 subunit hybrid domain (Mould et al., 2003;
Mould and Humphries, 2004)] with the high affinity activated
state can be established.
Multiple VLA-4-specific compounds, with binding affinities
spanning more than three orders of magnitude, were all capable
of inducing exposure of the hybrid domain epitope (Njus et al.,
2009). Moreover, a quantitative analysis of the fractional occu-
pancy of the VLA-4 ligand binding pocket revealed that EC50s for
the ligand-induced epitope exposure were virtually identical to
the Kis determined in the competition assay with the fluorescent
VLA-4 specific ligand. This suggests that occupancy of the VLA-
4 ligand binding pocket by a direct (competitive) VLA-4 ligand
is directly translated into HUTS epitope exposure, which can be
also detected in real-time (Chigaev et al., 2009; Njus et al., 2009).
This approach was recently adapted for the discovery of VLA-4
allosteric antagonists (see below) (Chigaev et al., 2011c,d).
EXTENSION AND AFFINITY
The inside-out activation through Gαi-coupled GPCRs induced
rapid VLA-4 extension that can be detected using a FRET-based
approach. In the presence of the ligand this created an extended
conformation with an exposed hybrid domain epitope. However,
in the case of wild type GPCRs the high affinity state existed only
for a fewminutes. After that, the binding affinity rapidly returned
to a resting low affinity state. On the contrary, VLA-4 molecular
extension detected using FRET persisted for several tens of min-
utes (Chigaev et al., 2007). This created a sustained low affinity
extended state that was similar to the state induced by Gαs-GPCR
induced deactivation (Chigaev et al., 2008) or the nitric oxide
(NO) and cGMP-dependent signaling (Chigaev et al., 2011a).
We envision that this state could sustain cell rolling. Significant
similarity between cAMP and cGMP-dependent signaling mech-
anisms, together with a specific role of cAMP-dependent guanine-
nucleotide-exchange factors for small GTPases (Rap1 and Rap2),
which are implicated in integrin-mediated cell adhesion (Bos,
2006), suggest that cyclic nucleotides may represent a uni-
versal, and previously underestimated mechanism of integrin
regulation.
Another VLA-4 state was observed after cell treatment with
phorbol ester. Phorbol 12-myristate 13-acetate rapidly elevated
VLA-4 affinity in a dose dependent manner. However, it failed
to stimulate any extension of the molecule as detected using
FRET.Moreover, the addition of calcium ionophore fully restored
VLA-4 extension (Chigaev et al., 2007). This led us to hypoth-
esize that cytoplasmic Ca2+ elevation is obligatory for molecu-
lar unbending, in contrast to the diacylglycerol-dependent step,
which regulates the affinity of the ligand binding pocket. The
recent finding that two adaptor proteins (talin-1 and kindlin-3)
can independently regulate LFA-1 integrin extension and ligand
binding affinity (Lefort et al., 2012) provides additional support
for our current model (Chigaev et al., 2007).
INTEGRIN CONFORMATION AND CELL ADHESION
How are multiple VLA-4 conformations translated into cell adhe-
sive properties? To address this question, see the data summarized
in Table 2. Two different approaches to study cellular behavior
for differing VLA-4 conformations were used: (1) real-time cel-
lular aggregation in solution in a VLA-4/VCAM-1 dependent cell
adhesion model system (Zwartz et al., 2004), and (2) cell rolling
in a parallel plate on low density recombinant human VCAM-1
(DiVietro et al., 2007).
The real-time analysis of cell aggregation in solution showed
a strong correlation between the initial rate of aggregation and
Table 2 | Behavior of VLA-4 conformational states using several approaches.
Cell treatment,
activation
(pathway)
Small fluorescent ligand
binding (LDV-FITC)a
Extension of the
molecule
(FRET-based assay)b
Real-time cell aggregation in
solutionc
Rolling on low
density rhVCAM-1d
Association
rate,
kon
Dissociation
rate,
koff
Overall
affinity
Initial rate of
cell
aggregation
Number of
aggregates at
steady state
Capture
frequency
Tether
duration
Resting state Fast Fast Low Bent Slow Low Low Short
fMLFF, FPR
activation (Gαi signal)
Fast Slow High Extended Rapid High High Long
Phorbol ester (PKC) Fast Slow High Bent Slow High Low Long
fMLFF + Forskolin
(Gαi and Gαs)
Fast Fast Low Extended Rapid Medium Low Short
aBased on data from Chigaev et al. (2001, 2003b, 2007, 2008).
bBased on data from Chigaev et al. (2003a, 2007, 2008).
cBased upon Chigaev et al. (2007, 2008).
dUnpublished data.
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the extension of VLA-4 detected using FRET. On the other hand,
the overall number of aggregates at steady state was related to the
overall ligand-binding affinity that was largely determined by the
dissociation rate of soluble ligand (LDV-FITC, koff, Table 2). It is
worth noting that such an unambiguous result was possible since
under the chosen experimental conditions only a small number
of VLA-4/VCAM-1 bonds were needed to form and sustain cel-
lular aggregates. According to an experimental estimate, in most
cases this number was less than three bonds per aggregate (Zwartz
et al., 2004). Thus, molecular extension seemed to facilitate the
initial VLA-4-VCAM-1 ligand interaction and therefore, promote
initial receptor engagement. Slow ligand dissociation, in the high
affinity state stabilizes cellular interactions, and therefore, results
in a larger number of cell aggregates.
In the parallel plate rolling assay at very low density of immo-
bilized ligands, the formation of multiple consecutive “bonds”
between receptor and its counter-structure is relatively unlikely.
Therefore, under these experimental conditions the kinetics of
transient tether formation and its dissociation provides insight
into the functional consequences of nascent adhesive contacts
(Grabovsky et al., 2000). We hypothesized that integrin extension,
because of the exposure of the ligand binding site, directly affects
the efficiency of tether formation. On the other hand, the affinity
of the binding pocket determines the life-time of the integrin-
ligand interaction and thus, regulates the duration of the adhesive
event. To test this idea we studied tether frequency and dura-
tion for the four affinity states described previously (Table 2).
The high affinity extended state of VLA-4 induced by stimulation
through a Gαi-coupled receptor produced rapid accumulation
of cells and long tether duration, when compared to the low
affinity bent resting state. Phorbol ester treated cells showed low
cell recruitment and long tether duration. This state was previ-
ously described as a high affinity bent conformation of VLA-4.
Treatment with fMLFF/forskolin (intended to reproduce cAMP
elevation through Gαs signaling), which generates a low affin-
ity unbent (extended) state, showed tether duration similar to
the resting cells. However, the tether frequency was unexpectedly
low for an unbent conformation. This unanticipated result might
result from our inability to accurately estimate the number of very
short tethers and merits further investigation. Thus, the parallel
plate data were generally consistent with the predicted behavior
except for the low affinity extended state to promote efficient cell
recruitment and adhesion (Chigaev et al., 2007).
Taken together, the overall scheme of the VLA-4 conforma-
tion regulation can be generalized as follows (Figure 1). At rest,
the low affinity bent conformation prevents cell tethering and
rolling because of the positioning of the ligand binding site. If
ligand engagement occurs, it would have a very short life time.
However, it is also possible that a series of engagements of inte-
grins or other receptors [selectins for example (Kuwano et al.,
2010)] could provide a signal resulting in molecular extension.
This could lead to rolling on an extended low affinity integrin.
Rapid activation by Gαi-coupled GPCR induces a short-lived high
affinity extended state (seconds to minutes), followed by a sus-
tained extended low affinity state. If during the short period that
VLA-4 engages its counter-structure, a long-lived tether will form.
Under shear and external force this interaction can potentially be
sustained for a longer period of time because of mechanical (catch
bond) or signaling/cytoskeletal events. If no engagement of the
integrin occurred, a low affinity extended state could be ideally
suited for rolling under shear.
LFA-1 CONFORMATION
A similar approach employing a small fluorescent ligand mim-
icking probe was used to study LFA-1 conformational regulation.
Because several small molecules, direct and allosteric antagonists,
are known to specifically bind to LFA-1, multiple fluorescent
probes based, for example, on BIRT0377 (Larson et al., 2005),
Genentech compounds (Gadek et al., 2002; Chigaev et al., 2011b),
and others can be used.
Employing this approach, recent studies of LFA-1 confor-
mational regulation revealed notable similarities and differences
in the regulation of VLA-4 and LFA-1. In a manner analo-
gous to VLA-4, LFA-1 can be rapidly activated by Gαi-coupled
GPCRs, with the overall activation time-frame dependent on the
rate of GPCR desensitization. Similar to VLA-4, LFA-1 can be
rapidly deactivated by Gαs-coupled GPCRs. Also similar to VLA-
4, modulation of the ligand dissociation rate can be observed for
different LFA-1 affinity states (Chigaev et al., 2011b). However,
unlike VLA-4, without inside-out activation (at rest), the bind-
ing of the fluorescent ligand to LFA-1 was extremely slow, at
least 10 times slower than was expected for diffusion-limited
binding. This suggests that an additional structural mechanism
prevents rapid binding of the ligand to resting LFA-1. In the
case of VLA-4 the binding of the ligand is unobstructed, and
ligand binding rates are close to the rates expected for the
diffusion-limited binding regardless of activation state, the kon
ranged from ∼3–5 × 106 M−1s−1 (Chigaev et al., 2001). We pos-
tulate that such a blocking mechanism explains the inability of
native LFA-1 to support cell rolling, where the absence of its
rapid engagement by the ligand in the inactive state leads to
the requirement for the selectin-mediated rolling step (Table 1)
(Chigaev et al., 2011b). A recent funding that rolling on E-
or P-selectin induces the extended but not high-affinity con-
formation of LFA-1 through a signaling mechanism triggered
by PSGL-1 engagement adds more complexity to the overall
scheme of LFA-1 conformational regulation (Kuwano et al.,
2010).
LIGAND BINDING RATES, I-DOMAIN, AND INTEGRIN
PHYSIOLOGY. IS THERE A RELATIONSHIP?
For adhesion receptors, the kinetics of ligand-receptor interac-
tion, which includes “bond” formation and its dissociation, is
a critical factor that determines the type of adhesive interac-
tion. The rapid forward rate (on-rate) is specifically important
for cell rolling, because of the requirement for rapid molecule
engagement under flow (Lawrence and Springer, 1991). As dis-
cussed above, the major difference between the two integrins is
that the on-rates for the binding of small ligands to VLA-4 and
LFA-1 are dramatically different. The on-rate for ligand bind-
ing to VLA-4 approaches the diffusion-limited binding rate for
a ligand of similar size (Chigaev et al., 2003b). For the LFA-1-
specific ligand, this rate is at least an order of magnitude slower.
We believe that this LFA-1-specific kinetic property is directly
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FIGURE 1 | Model of VLA-4 integrin conformation and affinity. The bent
low affinity state is observed on resting cells (I). Activation by phorbol ester
creates a high affinity state lacking molecular extension as detected by a
FRET-based approach (II). This conformation results in the slow accumulation
of cell aggregates in suspension (Chigaev et al., 2007), with a low tether
capture frequency but a long tether duration in the rolling assay (Table 2). The
addition of VLA-4 specific ligand to resting cells leads to exposure of a hybrid
domain (LIBS) epitope (III). However, the ligand binding affinity remains low
[see Figures 2, 4 in Chigaev et al. (2009)]. This state is bent (or at least not
fully extended) because a further molecular extension can be detected with a
FRET-based approach (Chigaev et al., 2003a, 2004, 2007). Activation through
a wild type Gαi-coupled GPCR induces a high affinity extended conformation
(IV). This conformation results in the rapid accumulation of cell aggregates in
suspension (Chigaev et al., 2007), with high tether capture frequency and
long tether duration (Table 2). The low affinity extended (or at least partially
extended) conformation (V) can be detected for several minutes after
signaling from wild type Gαi-coupled GPCR, because of relatively faster
desensitization of the ligand binding affinity than relaxation of the
conformation (Chigaev et al., 2007). Conformation V may also result from
consecutive stimulation through Gαi-coupled and Gαs-coupled receptors
(Chigaev et al., 2008). In suspension this translates into rapid cell aggregation
that reaches a steady-state intermediate between resting (I) and Gαi-coupled
GPCR activated states (IV) [see Figure 7A in Chigaev et al. (2008)]. A low
tether capture frequency and short tether duration was detected in the rolling
assay (Table 2) (see text for details). The ligand occupied and extended high
affinity state (VI) was detected after Gαi-coupled GPCR activation in the
presence of ligand. The molecule affinity and extension were preserved by
the use of a non-desensitizing GPCR mutant (Prossnitz, 1997; Chigaev et al.,
2003a, 2007). This conformation results in the rapid formation of a large
number of aggregates in cell suspension (Chigaev et al., 2008), with high
tether capture frequency and long tether duration in the rolling assay
(Table 2). The exposure of the hybrid domain (LIBS) epitope can be also used
to determine VLA-4 ligand binding affinity for unlabeled ligands (Chigaev
et al., 2009; Njus et al., 2009).
translated into the well documented inability of LFA-1 to sup-
port tethering and rolling under natural conditions (Lawrence
and Springer, 1991; von Andrian et al., 1991). These conditions
do not include the cases where LFA-1 conformation was changed
by mutations, I-domain isolation (Salas et al., 2002), or a small
molecule XVA-143 (Salas et al., 2004). We suggest that these
manipulations lead to a conformational change that facilitates
LFA-1 ligand binding site exposure, and therefore, promotes rapid
ligand-receptor engagement.
It worth noting that the possibility of a dramatic difference in
the ligand kinetics between VLA-4 and LFA-1 (and Mac-1) was
first suggested by Alon et al. (1995). These authors proposed that
for VLA-4, which can mediate tethering and rolling without cell
activation, rapid ligand association and dissociation rates would
be observed. This conclusion was based on the analogy with other
rolling receptors, i.e., selectins. These authors also suggested that
for the LFA-1 interaction with ICAM-1, the ligand binding kinet-
ics would be different (Alon et al., 1995). Now, experimental
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data directly supporting this concept are available (Chigaev et al.,
2011b).
Because amajor structural difference between VLA-4 and LFA-
1 is the presence of an additional “inserted” I-domain, which
was acquired by the I-domain containing leukocyte integrins at
the time their emergence, it is tempting to attribute the differ-
ence in ligand binding kinetics to the presence of the domain.
Without inside-out signaling, binding of ligand to LFA-1 is vir-
tually absent, leading to the hypothesis that, at rest, the LFA-1
ligand binding site is “shielded” by some part of the molecule
(Chigaev et al., 2011b). A rapid conformational rearrangement
of LFA-1 upon activation (Shamri et al., 2005) could release this
putative ligand binding site “protection,” and as a result mediate
rapid receptor engagement. The presence of such intra- or inter-
molecular “protection” is supported by the fact that an isolated
alpha L I-domain expressed on the cell surface was very effective
in supporting cell rolling (Salas et al., 2002). We propose that a
downward bending of the molecule that simply changes I-domain
orientation would be insufficient to prevent binding of a small
fluorescent ligand to LFA-1. In contrast, for VLA-4, the binding
of the small fluorescent probe was not obstructed in its bent con-
formation. The VLA-4-specific small fluorescent ligand binding
rate was close to its diffusion limit, where a FRET-based exten-
sion assay can be successfully performed (Chigaev et al., 2003a,
2004, 2007). We envision that a competitive protection mecha-
nism that can be similar to an “endogenous ligand” (Alonso et al.,
2002) could serve as a “shield” for the ICAM-1 binding site.
The physiological difference between the two integrins seems
to be related to the function of the immune system. VLA-4
appears to be more important for innate antigen-independent
immune responses, and LFA-1 for adaptive immunity. The pres-
ence of an additional protective mechanism for the binding of
a ligand to the LFA-1 binding site suggests that LFA-1/ICAM-
1-mediated interactions will be more difficult to establish. This
is not surprising to researchers who performed side-by-side
comparative studies of the two integrins. However, from a bio-
logical perspective, this seems to provide an additional “check”
for adaptive immune responses, where intercellular immune cell
interaction can directly lead to unwanted, or excessive immune
activation and result in cell and tissue damage. This notion is
additionally supported by the idea that the appearance of the
leukocyte-specific alpha I domain-containing integrins (such as
LFA-1) during vertebrate evolution coincides with the emergence
of the BCR-TCR-MHC-based adaptive immune system.
One apparent exception from this observation is the crucial
role of LFA-1 in chemokine-dependent arrest and trafficking of
neutrophils, which is traditionally envisioned as a part of innate
immunity. However, without questioning the well-established
role of neutrophils in the rapid destruction of infectious agents,
we would like to point toward emerging roles of neutrophils in
immune regulation. As recent reports suggest, neutrophils can
capture antigen and migrate to lymph nodes. They can also
produce a repertoire of cytokines, chemokines, and angiogenic
factors, provide signals for maturation of APCs, participate in the
immune cells crosstalk that includes B and T cells, regulate adap-
tive immunity, and participate in the resolution of inflammation
[for review see (Chakravarti et al., 2007; Kumar and Sharma,
2010; Mantovani et al., 2011)]. Thus, neutrophils should not be
only envisioned as innate “weapons of mass destruction,” but also
as emerging regulators of immune responses. Will some of these
functions require LFA-1 integrin for the mediation of immune
cell-cell interactions? We think that it is possible.
INTEGRIN PHYSIOLOGY AND ITS IMPLICATION FOR
DRUG DISCOVERY
Another remarkable difference between LFA-1 and VLA-4 inte-
grins is the type of integrin antagonists identified in the attempt
to regulate integrin dependent adhesion for therapeutic purposes.
A majority of compounds specific for VLA-4 and several other
integrins, including αIIbβ3 and αvβ3, are competitive (direct)
inhibitors (Shimaoka and Springer, 2003) (formally agonists that
promote LIBS). Until recently, no VLA-4-specific allosteric antag-
onists had been described (Chigaev et al., 2011d). For a com-
petitive drug, the ligand binding site location is very close (or
overlaps) with its natural ligand binding site. Therefore, direct
competition with the integrin natural ligand can be observed.
On the other hand, a large number of LFA-1 specific com-
pounds are allosteric antagonists for two different allosteric sites
on LFA-1 (Shimaoka and Springer, 2003). Is there a plausible
explanation that can account for such distinction? Can different
ligand binding properties provide an insight into such a peculiar
difference?
Direct competitive inhibitors are expected to be ineffective in
blocking LFA-1-dependent cell adhesion, if on resting cells, the
LFA-1 binding domain is “hidden” and only exposed after inside-
out activation. The binding of these compounds to LFA-1 would
only be possible after an inside-out signal. Because LFA-1 activa-
tion and engagement can occur locally, right on the spot, where
activating receptors, LFA-1, and ICAM-1 are juxtaposed at the
site of contact (Shamri et al., 2005; Laudanna and Alon, 2006),
competitive inhibitors would be highly inefficient in competition
with natural ligands. For integrins possessing a ligand binding site
that is exposed at rest (such as VLA-4), binding of competitive
inhibitors would occur at any time, and binding site occupancy
would simply depend on binding affinity and drug concentration.
On the other hand, binding of allosteric antagonists to their
binding site, which is spatially separated from the ligand bind-
ing pocket, should be independent of the natural binding site
exposure. Therefore, these compounds can occupy LFA-1 prior
to its activation, and thus, should be more efficient in block-
ing LFA-1-dependent cell adhesion. We postulate that because
of this property, in screening assays aimed at identifying LFA-1-
specific antagonists, the number of allosteric “hits” was artificially
enriched. This resulted in the predominance of LFA-1-specific
allosteric antagonists (Shimaoka and Springer, 2003).
Is it possible to identify allosteric antagonists for integrins
with an exposed ligand binding site? Using an approach that
relies upon the exposure of the Ligand Induced Binding Site epi-
tope (LIBS) to distinguish VLA-4 competitive antagonists (Njus
et al., 2009), several VLA-4-specific allosteric antagonists were
identified (Chigaev et al., 2011d). These molecules, although
not competing directly with VLA-4-specific ligands, blocked
VLA-4-dependent cell adhesion. Moreover, they mobilized early
hematological progenitors into the peripheral blood, which is a
www.frontiersin.org August 2012 | Volume 3 | Article 242 | 7
Chigaev and Sklar VLA-4 and LFA-1 conformational regulation
well-documented ability of anti-VLA-4 blocking antibodies or
competitive inhibitors (Bonig et al., 2008, 2009; Zohren et al.,
2008; Ramirez et al., 2009). Moreover, because several of the iden-
tified molecules are FDA approved drugs that have been used over
the past 30 years for treatment of non-hematological diseases, it
appears that these anti-VLA-4 allosteric properties account for
the previously reported hematological side effects (Chigaev et al.,
2011c).
CONCLUSIONS
An evolutionary divergence among ancient and more mod-
ern leukocyte integrins, containing an inserted alpha I-domain,
provides a plausible mechanism to account for structural and
functional differences between VLA-4 and LFA-1. A new set of
fluorescent approaches has made it possible to study the affinity
and conformation of these integrins in real-time on live cells at
natural receptor abundance using several homogeneous assays.
The ability of VLA-4 to bind ligand in the low affinity resting
state as well as the high affinity activated state allows it to serve
as an adhesion receptor for rolling as well as firm attachment.
The inability of LFA-1 to bind ligand in its natural resting state
suggests that its normal function is as a firm attachment recep-
tor in conjunction with selectins as rolling receptors. These ligand
binding differences provide an explanation to account for the fact
that VLA-4 inhibitors are typically competitive, while inhibitors
for LFA-1 are typically allosteric. Moreover, the ability of integrins
to independently regulate molecular extension as well as affinity
through known physiological pathways suggests ameans for inde-
pendent regulation of the adhesive capture efficiency as compared
to adhesive duration.
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